—
C+
C+ The full Closelook — membership. Open the C+ overview

Orion Oyj B (ORNBV.HE) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Orion Oyj B ranks 6 of 11 in its cohort on the Closelook composite (61/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ORNBV.HE Orion Oyj B 61 77 82 35 ok 1.4%
LLY Eli Lilly and Company 64 68 90 29 watch 10.8%
ORNAV.HE Orion Oyj A 61 77 82 35 ok 1.6%
SAN.PA Sanofi SA 57 45 68 65 watch 12.8%
NVO Novo Nordisk A/S 56 45 85 74 bull 30.2%
AMGN Amgen Inc 53 61 83 45 watch 15%
GRF.MC Grifols S.A. 48 47 41 81 warn 24%
BION.SW BB Biotech AG 74 73 95 81 info 8.4%
ARGX.BR Argen-X 64 78 73 28 ok 6.2%
ARGX argenx NV ADR 64 78 72 27 ok 7.2%
ANN.AU Ansell Ltd 63 90 44 55 ok 0.8%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Orion Oyj B's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Sanofi SA (SAN.PA), Novo Nordisk A/S (NVO), Amgen Inc (AMGN), Grifols S.A. (GRF.MC), BB Biotech AG (BION.SW), Argen-X (ARGX.BR) and others.

How does ORNBV.HE score against its peers?

Orion Oyj B's composite reads 61/100, ranking 6 of 11 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.